{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/08/3291010/0/en/Plus-Therapeutics-Announces-Oral-Presentation-Highlighting-REYOBIQ-Clinical-and-Translational-Data-Demonstrating-Favorable-Safety-Survival-and-Emerging-Immunomodulation-in-Leptomen.html", "message": "News view counter 712956 successfully enlarged"}